Search PubMed⌕ Search

Biomedical subjects

Douglas Powell

Publications and source records attributed to Douglas Powell.

33 records · Page 2Linked to original sources
PubMed2004

Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways.

Cells infected with two related retroviruses can generate heterozygous virions, which are the precursors of recombinant proviruses. Although many studies have focused on the frequencies and mechanisms of retroviral recombination, little is known about the dynamics of double infection. To examine this issue, viruses generated from two HIV-1 vectors containing different markers were mixed together, and were used to infect target cells. The numbers of cells expressing none, one, or both markers were measured and were used to calculate whether double infection occurred at frequencies expected from random infection events. We found that double infection occurred significantly more frequently than predicted from random distribution; increased rates of double infection were observed in both a T cell line and primary activated CD4(+) T cells. In addition to direct virus infection, we also examined the nature of cell-mediated HIV-1 double infection. Increased double infection was observed in all experiments regardless of whether a cell line or primary human dendritic cells were used for capture and transmission of HIV-1. Therefore, our results indicate that HIV-1 double infection occurs more frequently than it would at random in both direct and cell-mediated HIV-1 infections. To our knowledge, this is the first direct evidence of nonrandom double infection in HIV-1. Frequent double HIV-1 infections in infected individuals would allow the generation of recombinant viruses that could then affect their pathogenesis and evolution.

CD4-Positive T-Lymphocytes↗
PubMed2003

Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice.

The Ink4b gene (Cdkn2b) encodes p15(Ink4b), a cyclin-dependent kinase inhibitor. It has been implicated in playing a role in the development of acute myeloid leukemia (AML) in man, since it is hypermethylated with high frequency. We provide evidence that the gene is a tumor suppressor for myeloid leukemia in mice. The evidence is twofold: (1) retrovirus-induced myeloid leukemias of the myelomonocytic phenotype were found to have hypermethylation of the 5' CpG island of the Ink4b gene, and this could be correlated with reduced mRNA expression, as demonstrated by TaqMan real-time PCR. p15(Ink4b) mRNA expression in a leukemia cell line, with hypermethylation at the locus, was induced following treatment with 5-aza-2'-deoxycytidine. (2) Targeted deletion of one allele in mice by removal of exon 2 increases their susceptibility to retrovirus-induced myeloid leukemia. Mice deficient in both alleles were not more susceptible to myeloid disease than those deficient in one allele, raising the possibility that there are opposing forces related to the development of myeloid leukemia in Ink4b null mice.

Animals↗
PubMed2003

A ditopic azacryptate proton cage.

A tosylated azacryptand readily protonates at the bridgehead amines, becoming a potential ditopic anion receptor. The in-in conformation of the amines facilitates encapsulation of two bromide guests and represents the first structural evidence that a proton cage cryptate can bind two anions internally.

Journal Article↗
PubMed2003

New polyamide cryptand for anion binding.

An anion receptor derived from a tren-based amide cryptand with pyridine spacers has been synthesized and characterized. Two crystal structures are reported: the hydrochloride salt and the fluoride complex. The cryptand shows extremely high binding with fluoride ion in DMSO-d6. Both the crystal structure and solution 19F NMR data indicate an encapsulated fluoride ion with very high symmetry.

Journal Article↗
PubMed2003

Elite new anion ligands: polythioamide macrocycles.

Prototypes for a new class of polythioamide-based macrocycles have been synthesized and anion-binding capabilities assessed. Results indicate higher anion binding for H(2)PO(4)(-), HSO(4)(-), and F(-) for monocycles, but somewhat lessened binding capabilities for bicycles compared with amide corollaries.

Journal Article↗
PubMed2003

Anion receptors: a new class of amide/quaternized amine macrocycles and the chelate effect.

A new class of tetraamide macrocyclic receptors for anions with two quaternized amine functionalities exhibited higher affinities for anions compared with the corresponding neutral amides. In two crystal structures of halide complexes of the prototypes with phenyl and pyridine spacers, the anions are held by hydrogen bonding with the amide hydrogens. The pyridine analogues display higher affinities in general than the phenyl systems, a phenomenon which is attributed to the anion version of the chelate effect.

Journal Article↗
PubMed2003

Gestation stage-specific oxidative deoxyribonucleic acid damage from sidestream smoke in pregnant rats and their fetuses.

Transplacental exposure to environmental tobacco smoke (ETS) is a possible cancer risk factor in offspring. The authors exposed pregnant Sprague-Dawley rats to a relevant dose of ETS (1 mg/m3) from gestation day 4 to days 16 or 21. They then assayed tissues for levels of 8-oxo-2'-deoxyguanosine (8-oxo-dG), a marker of oxidative deoxyribonucleic acid damage. ETS exposure ending on gestation day 16 resulted in statistically significant increases in 8-oxo-dG in maternal liver and kidney and in fetal kidney. On gestation day 21, there were significant 8-oxo-dG increases in fetal liver and brain. These gestational stage- and tissue-specific increases of 1.2- to 1.4-fold are similar to the putative relative increases in risk of human cancers related to ETS.

8-Hydroxy-2'-Deoxyguanosine↗
PubMed2002

The effect of substituents on the phenyl portion of the imido ligand on the structure and properties of molybdenum(VI) imido complexes.

Anilines with alkyl substituents on the phenyl ring (ArNH2 = 2,4,6-trimethylaniline; 2,3-, 2,4-, 2,6-, and 3,4-dimethylaniline; and 2,6-diisopropylaniline) react with MoO(X)2(dtc)2 (X = Cl or Br; dtc = diethyldithiocarbamate) in methanol in the presence of 2 equiv of triethylamine to form ionic imido complexes of the type [MoNAr(dtc)3]2[Mo6O19] or MoNAr(dtc)3]4[Mo8O26]. The same reaction in THF with butyllithium as base yields imido complexes of the type MoNAr(X)2(dtc)2. The structures of three ionic, five chloro, and two bromo complexes have been determined by X-ray crystallography. In all complexes, the molybenum center is a distorted pentagonal bipyramid. While the structures are similar, the angles of the imido linkages differ. The effect of the substituents on the phenyl ring of the imido ligand on the 95Mo NMR chemical shifts was determined. The Mo nucleus becomes more deshielded with the substituents in the following order: 3,4-Me2 < 2,3-Me2 < 2,4-Me2 < 2,6-Me2 < 2,4,6-Me3 < 2,6 isopropyl. Complexes with more deshielded 95Mo centers tend to have angles of the imido linkage that are closer to 180 degrees.

Journal Article↗
PubMed2002

Synthesis and characterization of completely delocalized mixed-valent dicopper complexes.

The multidentate ligands tris[(N'-tert-butylureayl)-N-ethyl)]amine (H(6)1) and 1-(tert-butylaminocarbonyl)-2,2-dimethylaminoethane (H(2)2) have been used to investigate the assembly and properties of complexes with Cu(1.5)Cu(1.5) units. The complexes [Cu(H(5)1)](2)(+) and [Cu(H2)](2)(+) have been isolated and structurally characterized by X-ray diffraction methods. [Cu(H(5)1)](2)(+) has a Cu(1.5)Cu(1.5) core, with each copper ion having square planar coordination geometry. The copper ions are linked through two mono-deprotonated urea ligands, which coordinate as mu-1,3-(kappaN:kappaO) ureate bridges to produce a Cu-Cu distance of 2.39 A. The remaining two urea arms of [H(5)1](-) form intramolecular hydrogen bonds, the result of which is to confine the Cu(1.5)Cu(1.5) unit within a pseudomacrocycle. The structure of [Cu(H2)](2)(+) lacks intramolecular hydrogen bonds and thus does not have a pseudomacrocyclic structure. However, the structural properties of the Cu(1.5)Cu(1.5) core in [Cu(H2)](2)(+) are nearly identical to those of [Cu(H(5)1)](2)(+). Both complexes exhibit rhombic EPR spectra at 77 K, which do not change upon cooling to 4 K. The optical spectra of [Cu(H(5)1)](2)(+) and [Cu(H2)](2)(+) are dominated by an intense band at approximately 700 nm. These spectral characteristics are consistent with [Cu(H(5)1)](2)(+) and [Cu(H2)](2)(+) being classified as fully delocalized (type III) mixed-valent species.

Amines↗
PubMed2002

Increased serum corticosterone and glucose in offspring of chromium(III)-treated male mice.

Preconceptional carcinogenesis occurs in animals and is suspected for humans--for example, after occupational metals exposure. Several characteristics in animal models, including high frequency and non-Mendelian inheritance patterns, have suggested an epigenetic mechanism, possibly involving hormone changes in offspring. To test this hypothesis, we treated male mice with chromium(III) chloride, a preconceptional carcinogen, 2 weeks before mating, in two separate experiments. Their 10-week-old offspring showed highly significant increases in average serum corticosterone and glucose, compared with control offspring. Average serum levels of insulin-like growth factor 1 (IGF1) showed more modest possible increases. A previous microarray experiment identified hepatic insulin-like growth factor binding protein 1 (IGF BP1) gene expression as consistently changed in correlation with serum corticosterone levels. In the present study, hepatic IGF BP1 mRNA correlated with serum IGF1 in male offspring of chromium-treated fathers, but not in controls; serum glucose correlated positively with hepatic IGF BP1 in chromium-group offspring but negatively in controls. These results support the hypothesis that preconceptional exposure effects may alter hormones, metabolism, and control of tissue gene expression, probably through epigenetic mechanisms. Risk of neoplasia may be influenced by these changes.

Animals↗
PubMed1998

Synthesis and Characterization of Novel V/O/SO(4) Chains Incorporating 2,2'-Bipyridine Ligands: Crystal Structure of [V(2)O(2)(OH)(2)(SO(4))(2,2'-bpy)(2)].

The hydrothermal reaction of a mixture of vanadyl acetylacetonate (VO(acac)(2)), Na(2)SO(4), 2,2'-bipyridine (2,2'-bpy), and H(2)O for 48 h at 160 degrees C gives brown crystals of [V(2)O(2)(OH)(2)(SO(4))(2,2'-bpy)(2)] (1) in 70% yield. The structure of 1 consists of ribbons constructed from the infinite inorganic chains, [-{V(2)O(2)(OH)(2)}-&mgr;(2)-SO(4){V(2)O(2)(OH)(2)}-SO(4)](infinity), incorporating organic (2,2'-bipyridine) ligands. The inorganic chains are composed of the pairs of edge-sharing octahedra joined by {SO(4)} tetrahedra through octahedral-tetrahedral corner sharing. The octahedral geometry around each vanadium(IV) ion is defined by {VO(2)(OH)(2)N(2)} with each V(IV) center coordinated to a terminal oxo group, two &mgr;(2)-OH groups, two nitrogen donor atoms from a chelating 2,2'-bipyridine ligand, and an oxygen donor atom from a &mgr;(2)-SO(4)(2)(-) ligand. Crystal data for 1: monoclinic space group P2(1)/n (No. 14), a = 11.7937(2) Å, b = 12.1161(3) Å, c = 15.5763(2) Å, beta = 93.750(2) degrees, Z = 4. 1 constitutes the first example of a fully reduced vanadosulfate (V/O/SO(4)) based solid incorporating both the organic and inorganic ligands. The novel solid exhibits Curie-Weiss paramagnetism at high temperature (T > 140 K) and short-range antiferromagnetic coupling between the V(IV) centers at lower temperature.

Journal Article↗
PubMedDate not supplied

A novel retrovirus provides the cooperating oncogenic event(s) required to demonstrate the tumor suppressor activity of p15Ink4b in myeloid cells in vivo.

Cancer is a multistep process resulting from an accumulation of several genetic changes. The determination of cooperating events in experimental models can help scientists decipher specific neoplastic pathways and place genes with similar functions in complementation groups. In leukemia models, retrovirus tagging is a powerful approach to determine genes that cooperate with oncogenic transgenes or tumor suppressors that have undergone targeted deletion. Experimental models for B and T cell leukemias involving transgenic c-myc were the first to show the utility of retroviral tagging. Here we review these experiments and present examples of new models of myeloid leukemia where retroviruses have collaborated with a transgene [Cbfbeta-MYH111 from Inv(16)] and with loss of a tumor suppressor (Ink4b) mice to induce disease.

Animals↗
PubMedDate not supplied

Microarray analysis of altered gene expression in the TM4 Sertoli-like cell line exposed to chromium(III) chloride.

Chromium(III) chloride is a common human exposure metal that is a preconceptional carcinogen in mice, although it enters cells poorly, and is non-toxic and non-carcinogenic in most biologic systems. An indirect effect on sperm is postulated, and this effect might be mediated through the testicular Sertoli cells that influence spermatogenesis. To test this possibility, we exposed mouse TM4 Sertoli-like cultured cells to 1mM CrCl(3) x 6H(2)O, a non-toxic dose, for 7 days and then extracted mRNA for microarray analysis. The chromium(III) chloride had modest effects on the expression of many genes, in the range of 1.5-2.3-fold. These effects provided an opportunity for development of statistical approaches for sifting microarray data in a situation where differences were small. Data were winnowed by screening for those ratios that fell outside the 99% confidence limits and/or represented a > or = 50% change in expression in the three comparison pairs. Fifty-two genes/clones were significant after the Bonferroni adjustment for multiple comparisons. The largest average increase was observed for the transcription factor Bach2, and this increase was confirmed by RT-PCR. The results show that Cr(III) has significant effects on gene expression in a Sertoli-like cell line.

Animals↗
PubMedDate not supplied

A physiologic role for testosterone in limiting estrogenic stimulation of the breast.

OBJECTIVE: The normal ovary produces abundant testosterone in addition to estradiol (E(2)) and progesterone, but usually only the latter two hormones are "replaced" in the treatment of ovarian failure and menopause. Some clinical and genetic evidence suggests, however, that endogenous androgens normally inhibit estrogen-induced mammary epithelial proliferation (MEP) and thereby may protect against breast cancer. DESIGN: To investigate the role of endogenous androgen in regulating mammary epithelial proliferation, normal-cycling rhesus monkeys were treated with flutamide, an androgen receptor antagonist. To evaluate the effect of physiological testosterone (T) supplementation of estrogen replacement therapy, ovariectomized monkeys were treated with E(2), E(2) plus progesterone, E(2) plus T, or vehicle. RESULTS: We show that androgen receptor blockade in normal female monkeys results in a more than twofold increase in MEP, indicating that endogenous androgens normally inhibit MEP. Moreover, we show that addition of a small, physiological dose of T to standard estrogen therapy almost completely attenuates estrogen-induced increases in MEP in the ovariectomized monkey, suggesting that the increased breast cancer risk associated with estrogen treatment could be reduced by T supplementation. Testosterone reduces mammary epithelial estrogen receptor (ER) alpha and increases ERbeta expression, resulting in a marked reversal of the ERalpha/beta ratio found in the estrogen-treated monkey. Moreover, T treatment is associated with a significant reduction in mammary epithelial MYC expression, suggesting that T's antiestrogenic effects at the mammary gland involve alterations in ER signaling to MYC. CONCLUSIONS: These findings suggest that treatment with a balanced formulation including all ovarian hormones may prevent or reduce estrogenic cancer risk in the treatment of girls and women with ovarian failure.

Androgen Antagonists↗